HIV-1 phylogeny during suppressive antiretroviral therapy
MJ Bale, MF Kearney - Current Opinion in HIV and AIDS, 2019 - journals.lww.com
MJ Bale, MF Kearney
Current Opinion in HIV and AIDS, 2019•journals.lww.comUsing phylogeny to characterize HIV-1 genetic diversity and evolution during ART has
demonstrated a lack of viral replication, the proliferation of infected cells, and provides one
metric to measure the effect of new interventions aimed at achieving a functional cure for HIV-
1.
demonstrated a lack of viral replication, the proliferation of infected cells, and provides one
metric to measure the effect of new interventions aimed at achieving a functional cure for HIV-
1.
Summary
Using phylogeny to characterize HIV-1 genetic diversity and evolution during ART has demonstrated a lack of viral replication, the proliferation of infected cells, and provides one metric to measure the effect of new interventions aimed at achieving a functional cure for HIV-1.
Lippincott Williams & Wilkins